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Abstract: Ethanolic extracts from Mangifera indica L. have been proved to possess anti-tumor
properties in many cancer systems. However, although most effects have been demonstrated with
fruit pulp extract, the underlying molecular mechanisms of mango peel are still unclear. This study
was designed to explore the effects of mango peel extract (MPE) on colon cancer cell lines. MPE
affected cell viability and inhibited the colony formation trend of tumor cells, while no effects were
observed in human dermal fibroblasts used as a non-cancerous cell line model. These events were
a consequence of the induction of apoptosis associated to reactive oxygen species (ROS) production,
activation of players of the oxidative response such as JNK and ERK1/2, and the increase in Nrf2
and manganese superoxide dismutase (MnSOD). Significantly, mango peel-activated stress triggered
a DNA damage response evidenced by the precocious phosphorylation of histone 2AX (γH2AX),
as well as phosphorylated Ataxia telangiectasia-mutated (ATM) kinase and p53 upregulation. Mango
peel extract was also characterized, and HPLC/MS (High Performance Liquid Chromatography/Mass
Spectrometry) analysis unveiled the presence of some phenolic compounds that could be responsible
for the anti-cancer effects. Collectively, these findings point out the importance of the genotoxic stress
signaling pathway mediated by γH2AX in targeting colon tumor cells to apoptosis.
Keywords: mango; apoptosis; reactive oxygen species; γH2AX; colon cancer cells
1. Introduction
In recent years, many different findings have highlighted the beneficial value of food in the
prevention and/or as a supportive strategy of the most common therapies for the treatment of many
chronic diseases [1]. For these reasons, the term “functional food” is being used at an ever-increasing rate
to indicate the antioxidant, anti-tumor or anti-inflammatory properties of many bioactive compounds
extracted from plants or fruits [2–4].
In this scenario, particularly relevant seems to be mango (Mangifera indica L.), a crop belonging
to the Anacardiaceae family that, according to historical records, has been cultivated in India and
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Southeast Asia for more than 4000 years [5]. Nowadays, mango orchards are spread around the
world, in both tropical and subtropical environments, finding suitable areas for cultivation also in
the Mediterranean area, where their spread first started in Spain, then, together with other tropical
plants, also colonized Sicily, at least 20 years ago [6–8]. This fruit has received increasing interest from
consumers who perceived its importance as a functional food rich in phytochemicals able to provide
a healthy contribution to their diet.
Beyond the edible part of the fruit represented by the pulp (or mesocarp), the health-endorsing
properties of mango have been also attributed to other different parts of the fruit such as the seed coat
(endocarp), seed and peel (exocarp). In fact, although the pulp is endowed with a high polyphenolic and
carotenoid content represented by mangiferin, gallic acid, gallotannins, quercetin, isoquercetin, ellagic
acid, β-glucogallin and α- and β-carotene, many studies have supported the relevant composition
of the other parts of mango fruit. In this regard, it has been observed that the peel and seed, usually
discarded in fruit processing, are an important bio-source that can be exploited for their high content
of polyphenols (mangiferin, quercetin, rhamnentin, ellagic acid and kaempferol), carotenoids, dietary
fiber and vitamin E [9].
Several phytocompounds from different fractions of mango fruit have been shown to be powerful
free radical scavengers, anti-microbial compounds, anti-inflammatory mediators or cancer preventive
molecules [10], also exhibiting a strong cytotoxic activity towards many different human tumor models,
such as blood [11], lung [12], breast [13], colon [14] and prostate cancer cells [15]. The anti-tumor action
of mango extracts has been also demonstrated in vivo. In this regard, mango phenolic compounds
showed a chemotherapeutic potential for suppressing tumor growth in breast cancer xenografts in
mice, lowering the expression of a plethora of tumor associated proteins such as PI3K, AKT, hypoxia
inducible factor-1α (HIF1α), and vascular endothelial growth factor (VEGF) [16].
In recent years, many findings aimed at eradicating cancer have been focused on those compounds
that are endowed with a selective action, preferentially targeting tumors cells rather than normal ones.
Some of these compounds have been shown to be involved in inducing genotoxic stress, oxidative
injury and downregulation of protective and adaptive responses of tumor cells. From a therapeutic
perspective, there are many examples of well-established cytotoxic antineoplastic agents commonly
used for cancer treatment causing high levels of DNA damage by introducing double strand breaks
(DSBs), regulating cell cycle checkpoints and leading to cell cycle arrest and/or activating cell death
pathway [17,18]. When the genome of a cell is damaged or the action of genotoxins seriously affects
the DNA stability, the cell detects these changes and attempts to repair the damage, recruiting DNA
repair responses to avoid its transmission to daughter cells.
In this scenario DNA damage response activates a specific signaling pathway marked by the
phosphorylation of histone 2AX (H2AX) on Ser139, a canonical key component able to monitor repair
systems in DNA deeply affected by DBSs [19]. The phosphorylated form of H2AX (referred to as
γH2AX) represents a histone variant considered as a ‘protagonist’ in different cellular scenarios and
a reliable DNA DSBs biomarker [19]. To the best of our knowledge, γH2AX is the first marker that is
upregulated by DNA damage response and accumulates at the site of the damage where it is visualized
as foci, thus representing a sensitive tool to monitor cancer progression and efficacy of treatment [20].
With this in mind, our main focus was to explore the possible cytotoxic action of mango peel
extract on colon cancer cells. Although it is already known in literature that other portions of this fruit,
especially the endocarp, but also the pulp, are able to exert a cytotoxic action on tumor cells [14,21,22]
a very limited number of investigations have explored the mechanisms underlying the anti-cancer
properties of mango peel so far.
In addition, no data are available on the anti-tumor effect as well as on the phytochemical
profile of mango grown in the Mediterranean area. In light of these considerations, this study was
designed to investigate the anti-carcinogenic action of mango (M. indica L.) peel extract on colon cancer
cell lines and evaluate its phytochemical composition using HPLC/MS (High Performance Liquid
Chromatography/Mass Spectrometry) analysis.
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Our study demonstrates for the first time that mango peel induces a selective mechanism
of apoptotic cell death on colon cancer cells and that this effect is related to γH2AX-mediated
genotoxic stress.
2. Materials and Methods
2.1. Preparation of Mango Peel Extract
Mango fruits were washed and the peel was removed, cut into small pieces and lyophilized.
Afterwards, the small pieces were coarsely powered using a stainless steel grinder. The powder obtained
was then solubilized in a solution of 50% ethanol in phosphate buffered saline (PBS) to a final concentration
of 75 mg/mL and incubation was protracted overnight at 37 ◦C. Then, after centrifugation of the extract
at 120× g for 10 min, the supernatant was recovered and subjected to a further centrifugation at 15,500× g
for 10 min.
Hydro-alcoholic extract of mango peel (MPE) was stored at−20 ◦C until use. To perform treatments
with a range of MPE concentrations, working dilutions were prepared in cell culture medium. For these
experiments, cells were seeded, and after 24 h, when they covered the culture dish surface reaching
a 70% confluence, MPE was added and incubation was protracted for the times reported in the results.
Final concentration of ethanol employed as vehicle had no discernible effects on colon cancer cells
in comparison with control.
2.2. Reversed Phase HPLC/MS Experiments
Water, acetonitrile and formic acid HPLC/MS grade were used. HPLC samples were prepared
by dissolving the obtained powder extract in MeOH (1 mg/1 mL). The employed HPLC system was
an Agilent 1260 Infinity (Agilent Technologies Inc., Santa Clara, California, USA). A reversed-phase
column [Phenomenex Luna C18(2) (150 mm × 4.6 mm, particle size 3 µm, Phenomenex Inc., Bologna,
Italy) with a Phenomenex C18 security guard (4 mm × 3 mm), Phenomenex Inc., Bologna, Italy] was
used. A 0.5 mL/min flowrate was set and column temperature was 30 ◦C. Injection volume was
set at 25 µL. The used eluents were: phase A, 0.1% formic acid in water; phase B, 0.1% formic acid
in acetonitrile. Employed gradient: 0–5 min, 5% B (isocratic); 5–15 min, from 5% to 15% B (linear
gradient); 15–20 min, 15% B (isocratic); 20–25 min, from 15% to 30% B (linear gradient); 25–35 min, 30%
B (isocratic); 35–45 min, 5% B (washing and reconditioning). MS total ion counts (TIC) was employed
to monitor the eluate. Agilent 6540 UHD accurate-mass Q-TOF spectrometer (Agilent Technologies
Inc., Santa Clara, California, USA) with a Dual AJS ESI source (Agilent Technologies Inc., Santa Clara,
California, USA) was used to register mass spectra. All experiments were performed in negative
mode. Desolvation gas was N2 (300 ◦C, 8 L/min); nebulizer (45 psig), sheat gas (400 ◦C, 12 L/min).
The capillary potential was 2.6 kV and the fragmentor was 75 V. MS spectra range was 100–1000 m/z.
Gallic acid and Mangiferin standards were supplied by Sigma-Aldrich (St. Louis, MO, USA).
2.3. Cell Cultures and Compounds
HT29, Caco-2 and HCT116 colon cancer cells (Interlab Cell Line Collection, ICLC, Genoa, Italy)
and HDFa human fibroblasts (Gibco, Thermo Fisher Scientific, Monza, Italy) were cultivated in RPMI
1640 medium containing streptomycin (100 U/mL), penicillin (100 U/mL) and fetal bovine serum (10%)
(Life Technologies, Milan, Italy), which was added after heat inactivation. Cultures were maintained at
37 ◦C in a 5% CO2 humidified incubator as previously reported [23]. All reagents and compounds,
except where differently reported, were purchased from Sigma-Aldrich (Milan, Italy).
2.4. Cell Viability Assessment
Cell viability of different colon cancer cell lines (HT29 and Caco-2 adenocarcinoma cells and
carcinoma HCT116 cells) and human dermal fibroblasts (HDFa) was determined by a colorimetric
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assay based on the metabolic use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) by viable cells. The analysis was performed as previously reported [8].
Morphologic changes of cells were observed using a Leica DMR inverted microscope (Leica
Microsystems, Wetzlar, Germany) at 200×magnification. Pictures were acquired using a CCD camera
and processed using IM50 Leica software (Leica Microsystems, Wetzlar, Germany).
2.5. Clonogenic Assay
For the clonogenic assay, HT29, Caco-2 and HCT116 colon cancer cells (200 cells/well) were seeded
in 6-well plates and each condition was performed in triplicate. After 10 days, the cells were fixed
in methanol, stained with 0.01% crystal violet for 40 min at room temperature. Finally, the plates
were washed with water, air-dried and colonies containing more than 50 cells were counted manually.
As reported by Wang et al. [24], the survival fraction (SF) was evaluated using the formula SF = number
of counted colonies/number of plated cells × plating efficiency of the control group.
2.6. Analysis of DNA Damage and Cell Cycle Distribution
In order to determine changes in nuclear morphology the cells were stained with the bis-benzimide
derivative Hoechst 33342, as suggested by Kelly [25]. For these studies, 8 × 103 cells/well were seeded
in a 96-well plate and before treatment were stained with Hoechst 33342 (2.5 µg/mL medium) for
30 min. Then, cells were washed with PBS, resuspended in culture medium and incubated with MPE.
Morphological changes induced by MPE treatment were examined using an inverted Leica
fluorescent microscope (Leica Microsystems, Wetzlar, Germany) endowed with a 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI) filter. Leica Q Fluoro software was used for image acquisition.
Cell cycle analysis by DNA content quantification was performed using flow cytometry on
a Beckman Coulter Epics XL flow cytometer (Brea, CA, USA). For these analyses, cells were harvested,
pelleted using centrifugation at 120× g for 10 min. Cells were washed once in cold PBS and centrifuged
at 120× g for 10 min. Finally, 1 mL of propidium iodide hypotonic solution (50 µg/mL propidium
iodide, 0.1% sodium citrate, 0.1% Nonidet P40 and 100 µg/mL RNase A) was added to cell pellets
and incubation was protracted for 4 h in the dark at 4 ◦C prior to flow cytometry analysis. A total of
10,000 cells (events) for each sample were analyzed using FL3 channel (620 nm BP filter) to measure
propidium iodide fluorescence. Analysis of data was performed using the Expo32 software.
2.7. Acridine Orange and Ethidium Bromide Double Staining for the Detection of Apoptosis
Apoptosis was detected using a dual staining with acridine orange and ethidium bromide (AO/EB)
as reported by Ribble et al. [26]. Pictures were acquired using a fluorescent Leica microscope equipped
with Rhodamine and fluorescein isothiocyanate (FITC) filters. Merge images were obtained combining
pictures of both channels using Leica Q Fluoro software (Leica Microsystems, Wetzlar, Germany).
2.8. Assessment of Intracellular Generation of Reactive Oxygen Species
ROS generation was estimated using the fluorescent dye 5-(and-6)-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA). This compound passively enters into the cells
where, after modification by intracellular esterases, it can be oxidized from intracellular ROS. Colon
cancer cells (8 × 103/well) were incubated with MPE at various times. Lastly, the medium was replaced
and cells were incubated with 20 µM H2DCFDA at 37 ◦C for 30 min. Then, the medium was replaced
with PBS supplemented with 5 mM glucose, and after 20 min, the fluorescence was directly visualized
by means of a Leica fluorescence microscope (Leica Microsystems). Images were acquired using the
Leica Q Fluoro software using a FITC filter. The fluorescence was measured using a Varian CARY
Eclipse Fluorescence Spectrophotometer (Varian Medical Systems Italia SpA, Milan, Italy). Values
were given in terms of mean fluorescence intensity.
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2.9. Western Blotting Analysis
The analysis of proteins was carried out using western blotting. Briefly, after incubation with MPE,
cells were lysed and protein extracts were prepared as previously reported [27]. 30 µg proteins/lane
were resolved using SDS-PAGE and then electroblotted on a nitrocellulose membrane filter (Bio-Rad
Laboratories Srl). The identification of proteins was determined using specific antibodies (1:200).
Except for antibodies directed against caspase 9, PARP1 and ERK1/2 that were from Cell Signaling
Technology (Cell Signaling Technology Inc., Beverly, MA, USA), all other analyses of proteins were
carried out using primary antibodies distributed by Santa Cruz Biotechnology (Santa Cruz, CA, USA)
and secondary antibodies from Amersham, GE Healthcare Life Science (Milan, Italy). All detections
were performed using a ChemiDoc XRS System (Bio-Rad, Hercules, CA, USA) using Westar Ultra 2.0
enhanced chemiluminescence (ECL) reagent distributed by Cyanagen (Bologna, Italy). The intensity
of the protein bands was quantified using Quantity One software (Bio-Rad) and normalized against
a loading control protein that was not modified by the treatment and represented by γ-tubulin or
β-actin (diluted 1:1000; Sigma-Aldrich, Milan, Italy).
2.10. Statistical Analysis
GraphPad Prism 5.0 software package (San Diego, CA, USA) was used to perform statistical
analysis of data, which were shown as mean ± SD. The evaluation of significant differences between
untreated and treated samples was performed using a Student’s t test. Differently, for the analysis of
multiple groups, a one-way ANOVA test was applied. A p value < 0.05 was considered the threshold
for statistical significance.
3. Results
3.1. HPLC-ESI-QTOF-MS Analysis Reveals the Composition of Mango Peel Extract (MPE)
HPLC-ESI-QTOF-MS analysis evidenced the presence of 16 polar compounds in MPE (see Table 1
and representative trace in Figure 1). The identified compounds can be grouped in organic acids,
gallates and gallotannins, xanthones and benzophenone derivatives.
Three organic acids were identified: quinic acid (peak 2, at 6.70 min and m/z 191.0562), citric acid
(peak 6, at 8.39 min and m/z 191.0198) and gallic acid (peak 7 at 8.63 min and m/z 169.0141) (Figure 1).
The presence of these compounds was in agreement with literature for mango peel [9]. Different
compounds belonging to the family of gallates and gallotannins were also found: glucosyl gallate,
(peak 3 at 7.00 min and 331.0673 m/z), digallic acid (peak 11 at 25.46 min and 321.0255 m/z), tetragalloyl
glucose, (peak 13 at 26.31 min and 787.0998 m/z), methylgallate, (peak 14 at 26.36 min and 183.0301 m/z),
pentagalloyl glucose, (peak 15 at 26.73 min 939.1100 m/z) and methyl-digallate ester, (peak 16 at 29.68 min
and 335.0411 m/z). Peak 8, 11 and 12 were identified as three O-glucoside derivatives of benzophenone
maclurin. Concerning xanthones, at 25.01 min and 421.0776 m/z (peak 9) mangiferin was found.
According to data previously reported in literature [9], the identification of galloylated benzophenone
derivatives in mango peel provides evidence that galloylation of mangiferin and isomangiferin occurs
before cyclization of benzophenones in the biosynthetic pathway. From a phytochemical point of
view, the detection of galloylated maclurin could help to clarify the biogenesis of xanthone derivatives
in mango.
In addition, lepidimoic acid was identified as peak 5 at 7.70 min with 965.2625 [3M − H]− m/z.
Lepidimoic acid was recently reported as a novel allelopathic substance, which has potent stimulating
activity for the growth of other plant species [28]. To our knowledge, this is the first time that lepidimoic
acid has been identified in mango fruits.
Table 1 also reports the quantification of free polar compounds in MPE, expressed as mg/100 g dry
matter. Quantification of mangiferin and gallic acid was performed with the calibration curves of their
own standards. According to previous studies, the gallates, gallotannins and maclurin derivatives
were quantified using the calibration curve of gallic acid [29].
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Table 1. Composition of mango peel extract (MPE).
Compound RT (min)
ESI−
[M − H]− (m/z) Molecular
Formula
mg/100 g
Teor. Exp.
1 Disaccaride 6.22
341.1089 [M − H]−
377.0856 [M + Cl]−
387.1144 [M + FA]−
341.1090 [M − H]−
377.0857 [M + Cl]−
387.1145 [M + FA]−
C12H22O11 ND a
2 Quinic acid 6.70 191.0561 [M − H]− 191.0562 [M − H]− C7H12O6 ND a
3 Glucosyl gallate 7.00 331.0671 [M − H]− 331.0673 [M − H]− C13H16O10 108.14
4 Gluconolactone 7.53 223.0459 [M + FA]− 223.0460 [M + FA]− C6H10O6 ND a
5 Lepidimoic Acid 7.70 965.2627 [3M − H]− 965.2614 [3M − H]− C36H54O30 ND a
6 Citric acid 8.39 191.0197 [M − H]− 191.0198 [M − H]− C6H8O7 ND a
7 Gallic acid 8.63 169.0142 [M − H]− 169.0141 [M − H]− C7H6O5 118.57
8 Maclurinmono-O-galloyl-glucoside 24.74 575.1042 [M − H]
− 575.1041 [M − H]− C26H24O15 72.03
9 Mangiferin 25.01 421.0776 [M − H]− 421.0776 [M − H]− C19H18O11 2.81
10 Maclurin di-O-galloylglucoside 25.34 727.1152 [M − H]
− 727.1145 [M − H]− C33H28O19 20.21
11 Digallic acid 25.46 321.0252 [M − H]− 321.0255 [M − H]− C14H10O9 Trace
12 Maclurintri-O-galloyl-glucoside 26.21 879.1262 [M − H]
− 879.1253 [M − H]− C40H32O23 6.05
13 Tetragalloyl glucose 26.31 787.0999 [M − H]− 787.0998 [M − H]− C34H28O22 4.88
14 Methylgallate 26.36 183.0299 [M − H]− 183.0301 [M − H]− C8H8O5 225.87
15 Pentagalloyl glucose 26.73 939.1109 [M − H]− 939.1100 [M − H]− C41H32O26 17.89
16 Methyl-digallate ester 29.68 335.0409 [M − H]− 335.0411 [M − H]− C15H12O9 487.15
a Not determined.
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Figure 1. Representative high performance liquid chromatography-electrospray-ionization-quadrupole-time
of flight (HPLC/ESI/Q-TOF) trace of mango peel extract.
MPE presented free polar compounds of all the families. As usually observ d f r tropical fruits,
phenolic acid derivatives, in particular the gallic acid derivatives, are abundant. Methyl esters of gallic and
di-gallic acids were the major compounds with concentrations of 487.15 mg/100 g and 225.87 mg/100 g,
respectively. Gallic acid derivatives have shown high antioxidant activity and health benefits ranging from
neuroprotective action [30] to anti-cancer activity in many tumor systems [31].
3.2. MPE Induces Cytotoxic Effects and Morphological Changes in Colon Cancer Cells
To estimate the effects of MPE on different colon cancer cells, we performed cell vi bility tests using
MTT colorimetric assay. For these studies, HT29, Caco-2 and HCT 6, three different colon cancer cell
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lines, were screened at 24 h and 48 h after administration of different concentrations (15–600 µg/mL) of
MPE. The analysis was performed in comparison to HDFa, primary human dermal fibroblasts isolated
from adult skin, which was used as a non-tumor control, as previously reported [32]. As shown in
Figure 2A, already after 24 h MPE treatment reduced cell viability of all the analyzed colon cancer cells
in a dose-dependent manner. The effect started at 180 µg/mL MPE, and at 600 µg/mL concentration the
evaluated residual viability amounted to 46%, 35% and 44% in HT29, Caco-2 and in HCT116 cells,
respectively. This effect further increased by prolonging the incubation time of cells in the presence of
MPE, reaching the maximum at 48 h of treatment with 360 µg/mL dose. In comparison, no significant
cytotoxicity was observed when MPE was assayed on normal HDFa (−12%).
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Figure 2. MPE effects on cell viability and the level of proliferation marker proliferating cell nuclear
antigen (PCNA) in human dermal fi robl sts and colon cancer cell lines. (A) Hum n dermal fibroblasts
(HDFa) and colon cancer cells (HT29, Caco-2 and HCT116) were incubated in the presence of different
concentrations of MPE for 24 and 48 h as reported in the Materials and Methods section. Then, the
percentage of viable cells was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. The values reported in the line chart are the means of three independent
experiments ± SD. Statistical significance was assessed using the Student’s t-test: (*) p < 0.05, (**) p < 0.01
and (***) p < 0.001 compared to the untreated sample. (B) Morphological changes induced by 360 µg/mL
MPE were acquired after 48 h of treatment by an inverted Leica microscope. A picture taken at a 200×
magnification by IM50 Leica software is reported in the figure. (C) Western blotting a alysis of PCNA
protein expression in HDF and colon cancer c lls. The correct protein loading was ascertained by
immunoblotting for γ-tubulin. D nsito etry values are averaged from thre independent experiments
normalized to γ-tubulin. (*) p < 0.05 compared to the untreated sample. N.S., not significant.
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Having demonstrated that a consistent growth inhibitory effect occurs using 360 µg/mL MPE and
that higher doses (600 µg/mL) induce unspecific cytotoxicity, all succeeding experiments were carried
out using a 360 µg/mL dose.
As shown in Figure 2B reporting light microscope images, a large portion of colon cancer cells
exposed to MPE treatment detached themselves from the substrate and exhibited clear morphological
changes, such as cell shrinkage, roundness, and a vivid cell density reduction in comparison to the
untreated cells. In contrast, these alterations were not visible in the normal control cell line HDFa,
which appeared as a uniform array of cells abutting each other in both untreated and MPE treated
conditions (Figure 2B).
The ability of MPE to inhibit cell growth was also confirmed using western blotting analysis of
the proliferating cell nuclear antigen (PCNA, Figure 2C), a well-known marker of cell proliferation
whose level was decreased by MPE treatment in all colon cancer cells.
3.3. MPE Treatment Inhibits Clonogenic Ability of Colon Cancer Cells
The inhibition of colon cancer cell proliferation was also confirmed by clonogenic assay (Figure 3),
which measures the ability of single cells to proliferate, forming colonies containing at least 50 cells.
The clonogenic potential is an important aspect of cancer behavior since it is strictly related to recurrence
and metastatic ability.
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in Materials and Methods, was evaluated after 10 days. Pictures of a repres nta ive experiment are
reported. In the right panel statistical results of colony-forming assays were repo ted as su vival fraction
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Using different MPE doses (15–90 µg/mL), we observed that a concentration of 15 µg/mL MPE
significantly reduced the clonogenic efficiency in Caco-2 (−36.4%) and HCT116 (−33.1%) cells, while
modestly affected that of HT29 cells (−17.2%) (Figure 3) with respect to the clonogenic rate of untreated
cells. The colony forming trend almost disappeared in both Caco-2 and T116 cells with 30 µg/mL,
while such an effect occurred at a higher dose (90 µg/mL) in HT29 cells.
Taken together, these results highlight the ability of MPE to counteract the proliferative trend of
colon cancer cells, reducing their viability and clonogenic potential.
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3.4. MPE Triggers DNA Fragmentation and Apoptotic Cell Death in Colon Cancer Cells
Next, to investigate the nature of the cytotoxic effect of MPE we explored whether its action was
accompanied with changes in the DNA integrity and activation of apoptotic cell death. As is evident
from the cellular DNA content histograms reported in Figure 4A, MPE stimulation affected the cell
cycle distribution of cells, promoting the accumulation of a remarkable percentage of cell population
in the SubG0-G1 phase of the cell cycle with fragmented DNA, a hallmark of apoptotic cell death.
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Such data was also corroborated by acridine orange/ethidium bromide double staining, which
identifies morphological apoptosis-associated changes of cells [33]. Indeed, data provided evidence
that MPE-treated cells are characterized by the presence of granular yellow-green nuclear staining
(early apoptotic cells) or condensed orange nuclear staining (late-apoptotic cells), whereas a prevalence
of diffuse green fluorescence was observed in untreated cells, indicating live cells (Supplementary
Data, Figure S1).
The induction of apoptosis was also confirmed by the decrease in the level of both pro-caspase-9
and -3 as well as PARP1 breakdown, a known caspase-3 substrate (Figure 4B).
3.5. Assessment of Oxidative Stress Mediated Signaling in MPE-Treated Cells
It is well known that the DNA fragmentation can be a consequence of oxidative stress
generation [34]. Thus, we estimated the ROS level by assessing cell ability to oxidize the fluorochrome
H2DCFDA, a dye employed as a general indicator of cellular ROS. A time course analysis (Figure 5A)
showed that the ROS level rapidly raised in MPE-treated cells, reaching the maximum at 30 min–1 h
in all three colon cancer cells, when almost 90% of cells exhibited a pronounced green fluorescence
detectable using either fluorescence microscopy or a fluorescence spectrophotometer. Thereafter, the
effect was reduced, dropping to 35–40% of green fluorescent cells at 24 h of MPE exposure.
The addition of apocynin, a NADPH oxidase inhibitor, markedly reduced the ROS level at 1 h
of treatment, thus suggesting the involvement of this multi-complex system in ROS generation. It is
also interesting to note that the addition of N-acetylcysteine (NAC), a quencher of ROS, although
it efficaciously rescued the early ROS production (30 min–2 h, Figure 5A), did not counteract MPE
cytotoxicity observed after longer times of treatment (24–48 h, Figure 5B). These data strongly support
the participation of ROS in MPE-mediated cytotoxic mechanism in the first phase of treatment.
The successive analysis evidenced that the observed events were accompanied by changes in
cellular protein levels that are the main players of the cell response to stress. Firstly, we analyzed the
phosphorylated extracellular signal-regulated protein kinases 1 and 2 (pERK1/2), mitogen-activated
protein kinase family members that can be involved in cell proliferation, apoptosis and stress [35].
In accordance with the precocious ROS generation, pERK1/2 increase occurred in an early phase of
incubation with MPE (1–8 h, Supplementary Data, Figure S2) and remained high up to 48 h (Figure 6),
albeit it was counteracted by NAC addition only in the early phase of treatment (Supplementary Data,
Figure S2). As reported in Figure 6, a remarkable increase in the level of pERK1/2 was observed after
MPE exposure in all colon cancer cells analyzed.
The same treatment condition also promoted the upregulation of other MAP kinases involved in
stress, such as phosphorylated JNK (pJNK), although its increase was less pronounced compared to
that observed for pERK1/2.
In the next phase of our experiments, studies were carried out to ascertain whether cytoprotective
events were activated in MPE-induced mechanism as a result of cell stress response. In this regard, the
analyses were focused on two enzymes with antioxidant properties such as manganese superoxide
dismutase (MnSOD), an oxidoreductase that removes the highly toxic radical species superoxide
anion (O2•−), and catalase, an enzyme that detoxifies cells from hydrogen peroxide (H2O2). These
two enzymatic activities represent important defensive systems that cells usually employ to detoxify
themselves as a result of ROS overload [36]. As highlighted in Figure 7, in HT29 cells a considerable
increase in the levels of MnSOD was determined compared to the untreated control cells after 48 h of
treatment, while the levels of catalase remained substantially unchanged.
We also wondered whether the increase in MnSOD was associated with an increase in nuclear
factor erythroid 2-related factor 2 (Nrf2), a transcription factor that, when phosphorylated and active,
promotes the expression of antioxidant target enzymes such as MnSOD and catalase [37]. Western
blotting analysis revealed the upregulation of Nrf2 upon MPE treatment for 48 h, an effect that was
accompanied by the appearance of a band at a slower electrophoretic mobility corresponding to the
phosphorylated form of the factor (Figure 7).
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Taken together, these results seem to indicate that the early ROS generation, promoting both
a widespread oxidative injury as well as pERK1/2 and pJNK upregulation, plays a role in the cytotoxic
behavior of MPE.
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Figure 7. MPE treatment upregulates antioxidant responses. Colon carcinoma HT29 cells were exposed
to MPE treatment for 48 h. Then, cells were lysated and proteins were analyzed using western blotting
by using specific antibodies directed against MnSOD, catalase and Nrf2, as reported in Materials
and Method section. The correct protei loading was ascertai ed by immunoblotting for β-actin.
Representative blots of three independent experiments and densitometry analysis histograms are
depicted. (*) p < 0.05 and (**) p < 0.01 compared to the untreated sample. N.S., not significant.
3.6. DNA Fragmentation and Apoptotic Cell Death Induced by MPE is Related to γH2AX-Mediated Genotoxic
Stress
To demonstrate that the effect of MPE is related to the induction of DNA damage, cells were stained
with vital Hoechst 33342, a specific dye that allows the identification of DNA damage associated with
chromatin condensation and fragmentation, as indicated by Kelly [25]. As can be seen in Figure 8A,
untreated cells show a weak diffuse blue color given by the dye. On the contrary, when all three
colon cancer cells were incubated with MPE the presence of an intense brilliant blue hue, an index of
chromatin condensation and fragmented DNA, was observed.
In relation to the experimental evidence obtained, we turned our attention to the molecular events
responsible for DNA damage, blockage of cell proliferation and oxidative stress injury. Firstly, we
analyzed the phosphorylated form on serine 139 of H2AX histone, referred to as γH2AX. This protein,
indeed, when activated by phosphorylation by the serine/threonine kinase ATM [38], represents an
efficient system of recognition and repair of DNA double helix breaks [19]. Figure 8B shows that MPE
treatment induced a consistent increase in γH2AX level as well as in the phosphorylated ATM protein
(pATM) in all colon cancer cells, suggesting the recruitment of this repair system at DNA breaks.
On the other hand, e involvement of the above-mentioned stress pr teins as players correlat d to
γH2AX ncrease cannot be excluded. In fa t, b yond pATM, H2AX phosphorylation could also be
ascrib to other kinases such as pJNK [39], which in our experimen al conditions was upregulat d by
MPE treatme (Figure 6), or the phosphorylat d form of the ki ase p38 [40].
Importantly, the DNA damage effect in treated Caco-2 a d HCT116 cells was lso accompanied
by an inc ease i p53 level, the genome guardian protein capable of orchestrating a variety of DNA
damage responses (DDR) and inducing apoptotic cell death [41]. In contrast, such an effect was not
observed in HT29 cells, which are known to express a mutated form of this protein [42–44].
To explore a possible relationship between oxidative stress and DNA damage in MPE-treated cells,
we further characterized the molecular mechanisms underlying MPE-mediated apoptosis in HT29.
As depicted in Figure 9, the increase in γH2AX occurred precociously in stimulated cells appearing
after 1 h and 8 h of incubation, thus suggesting the recruitment of this protein had already taken place
in the first phase of treatment in concomitance with ROS generation. Indeed, the MPE-induced extent
of γH2AX was conditioned by the addition of NAC, the quencher of ROS that, when co-administrated
with MPE, completely suppressed the phosphorylation of H2AX in the first hour of exposure, an effect
that disappeared for longer times of incubation (8 h).
Antioxidants 2019, 8, 422 14 of 21
Antioxidants 2019, 8, x FOR PEER REVIEW 15 of 23 
shows that MPE treatment induced a consistent increase in γH2AX level as well as in the 
phosphorylated ATM protein (pATM) in all colon cancer cells, suggesting the recruitment of this 
repair system at DNA breaks. On the other hand, the involvement of the above-mentioned stress 
proteins as players correlated to γH2AX increase cannot be excluded. In fact, beyond pATM, H2AX 
phosphorylation could also be ascribed to other kinases such as pJNK [39], which in our experimental 
conditions was upregulated by MPE treatment (Figure 6), or the phosphorylated form of the kinase 
p38 [40]. 
Importantly, the DNA damage effect in treated Caco-2 and HCT116 cells was also accompanied 
by an increase in p53 level, the genome guardian protein capable of orchestrating a variety of DNA 
damage responses (DDR) and inducing apoptotic cell death [41]. In contrast, such an effect was not 
observed in HT29 cells, which are known to express a mutated form of this protein [42–44]. 
 
Figure 8. MPE effects on DNA damage markers. (A) The effect of MPE on DNA was evaluated using 
Hoechst 33342 staining in colon cancer cells incubated with MPE for 48 h. The pictures (original 
magnification 400×) were acquired using a 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
filter with a Leica fluorescent inverted microscope using Leica Q Fluoro software. Yellow arrows 
Figure 8. MPE effects on DNA damage markers. (A) The effect of MPE on DNA was evaluated using
Hoechst 33342 staining in colon cancer cells incubated with MPE for 48 h. The pictures (original
magnification 400×) were acquired using a 4′,6-diami ino-2-phenylindole dihydrochloride (DAPI)
filter with a Leica fluorescent inverted microscope using Leica Q Fluoro softwa e. Yellow arrows
indicate condensed or f agmented chromatin. (B) MPE provoked the phosphoryl tion of both H2AX
(γH2AX) and ATM (pATM) and p53 upregulation. All colon cancer cells (HT29, Caco-2 and HCT116)
were treated for 48 h in the presence of 360 µg/mL MPE. Then, cell lysates were analyzed using western
blotting with specific antibodies directed against the proteins of interest, as reported in Materials and
Methods. The correct protein loading was ascertained by immunoblotting for γ-tubulin. Representative
blots of three independent experiments and densitometry analysis histogram normalized to γ-tubulin
are reported in the bottom panel. (*) p < 0.05, (**) p < 0.01 and (***) p < 0.001 compared to the untreated
sample. N.S., not significant.
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Figure 9. MPE promotes early activation of γH2AX via oxidative stress. HT29 cells were treated with
MPE for the indicated times in the presence or absence of NAC. Lastly, western blotting analys s ere
performed in order to study the eff cts of the tr atments on the otal lev l of γH2AX. The corr ct
rotein loading was ascertained by immunoblotting for β-actin. The results are representative of three
independent experiments and ensito etry analysis histograms are reported normaliz d to β-actin. (*)
p < 0.05 and (***) p < 0.001 compared to the untreated sample. (##) p < 0.01 compared to MPE-treated
sample. N.S., not significant co pared to MPE-treated cells.
4. Discussion
Thi paper aimed at analyzing mango peel extract for its ability to tackle the tumor behavior of
different human colon cancer cells and explore its mode of action.
The choice of this analysis was sustained by the observation that many studies report the health
endorsing properties of mango from tropical areas, while no data are currently available on peel from
mango cultivated in Sicily (Balestrate, Italy), especially on its anti-cancer activity. Sicily is characterized
by a particular pedoclimatic environment that seems to be favor ble for mango cultivation conferring
particular prop rties to the orchards. For this pur ose, we were interested in characterizing the
c emical composition of MPE obtained from mango grown in the rural Sicilian areas s well as to test
its effects on tumor cell systems.
Significantly, our results provided evidence that MPE exhibits a selective anti-carcinogenic actio
gainst colon carcinoma cells inducing a γH2AX- ediated genotoxic and apoptotic effect, while
it turned out to be ineffective on human dermal fibroblasts. MPE effect is accompanied by early
ROS generation causing both the activation of phosphorylated stress proteins (as pJNK) as well as
an extended DNA damage that committed colon cancer cells to γH2AX-mediated apoptotic demise.
Overall, these data are in accordance with results demonstrating that the increase of pJNK could be
also ascribed to the activation of an apoptotic cell death program, as recently shown in cells of chronic
myeloid leukemia treated with resveratrol [45], one of the main polyphenols present in plants.
We also demonstrated that MPE promotes the upregulation of pERK1/2, members of the
mitogen-activated protein kinase family capable of mediating cell proliferation, apoptosis [35] and
inducing ROS-mediated NADPH oxidase [46]. Beyond the activation of the stress kinase pJNK and
pERK1/2, the oxidative injury sparked by MPE treatment was also accompanied by the recruitment of
Nrf2, a well-known repair system active in the defense and protection of cells from toxic and oxidizing
events. Nrf2 is a transcription factor that, when phosphorylated [47,48], translocates into the nuclear
environment where it transactivates the expression of a battery of genes with antioxidant action such as
superoxide dismutase (MnSOD), catalase, NAD(P)H quinone reductase, glutathione S-transferase and
HO-1 [37,49]. Our experiments have highlighted that the activation of protective responses such as
Nrf2 and its target MnSOD probably attempt to counteract MPE-mediated oxidative injury.
Taken together, these data, supporting the participation of oxidative stress in the MPE effect,
lead us not to exclude a possible involvement of NO and nitrosative stress in our systems, which we
aim to investigate in future. Indeed, NO exhibited a dual action on many cancer models, enhancing
cell permeability and retention of chemotherapeutics as well as killing tumor cells [50]. On the other
hand, our chemical characterization of MPE using HPLC/MS indicated the presence of mangiferin,
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a well-known bioactive xanthone that has been proved to increase both NO production and eNOS
expression in some cell systems [51]. Such an aspect could be of particular interest since some NO
inducers or NO-donating compounds have been recently identified as new, promising anticancer
therapeutics against blood and solid tumors [52–55].
In addition to the extended DNA damage promoted by MPE, as well as an increase in γH2AX
level, an increase in that of pATM and p53 was also observed. As reported in the literature, γH2AX
represents the first step for the recruitment of DNA repair proteins at the damaged sites. H2AX is
one of the main five histones belonging to the H2A histone protein family, whose relevance has been
highlighted for its phosphorylated form at ser139, referred to as γH2AX, and that represents a sensitive
indicator of damaged DNA by environmental and exogenous insults [56]. These observations are in
accordance with our data showing γH2AX increase related to the apoptotic cell death induced by
mango peel. The level of γH2AX rapidly increased in the early phase of treatment and remained
high along all the process that committed colon cancer cells to apoptotic demise. These data were in
accordance with Rogakou [57] who, studying the kinetic of γH2AX formation in Jurkat cells exposed
to the effective apoptotic inducer staurosporine, provided a detailed examination of γH2AX timing
and DNA fragmentation of dying cells. Similar effects were also described in other apoptotic systems
such as staurosporine-treated HL60 cells [58] and etoposide-treated Jurkat cells [57]. Solier et al. [59]
also analyzed the presence of γH2AX and phosphorylated H2B in a novel cell entity named apoptotic
ring, where the histone variants are recruited and activated by DNA damage response kinases. In line
with this observation, more recently a novel apoptotic signaling pathway dependent on the activation
of the H2AX-CARP1 (cell cycle and apoptosis regulatory protein) axis has been demonstrated as a key
event in the transduction of apoptosis following DNA damage [60].
On the whole, the data reported here provide evidence that MPE stimulation triggered an apoptotic
cell demise orchestrated by ROS-mediated genotoxic stress and a remarkable increase in γH2AX level.
However, since these effects had already appeared in the first hours of incubation, when cells are still
alive, it is conceivable that along the pathway that commits cells to death, tumor colon cells try to
activate cytoprotective systems such as Nrf-2 and its transcriptional target MnSOD, which hopelessly
fail in sustaining tumor survival. Thus, cells become disarmed in their defense systems and collapse
by apoptosis. A schematic representation of MPE anticancer activity on colon cancer cells is reported
in Figure 10.
Interestingly, the characterization of the polyphenolic profile of MPE using HPLC/MS provided
evidence that different families such as organic acids, gallates and gallotannins, xanthones and
benzophenone derivatives enrich this fruit and could be the main players in the analyzed mechanism.
In addition, differently from other previous studies, we demonstrate for the first time the presence of
lepidimoic acid, a pectic disaccharide, in mango peel. To our knowledge, this is the first evidence of
this compound in mango.
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Figure 10. Schematic representation of the mechanism of action of MPE on colon cancer cells.
MPE treatment promotes oxidative stress injury evidenced by ROS generation and activation of
stress-mediated responses (pERK1/2 and pJNK) as well as DNA fragmentation. The activation of
γH2AX in response to DNA damage causes the commitment to apoptotic demise.
5. Conclusions
Overall, our results correlate with data present in the literature on the anti-tumor action of
mango peel extract. However, here we provide a new insight into the mechanism of action of MPE
preferentially targeting colo cancer cells rather than normal ones. The chemical characterization
of MPE sheds light on the composition of possible phytochemicals responsible for t ese selective
properties. Moving forward, our future studies will aim to better un erstand the role of molecules
contained in MPE. To this purpose, the different phytochemicals found in MPE will be tested alone or in
combination in future investigations to explore possible synergistic interactions. In addition, a putative
action of MPE in combination with the most common chemotherapeutics will be also considered with
the aim to provide a new insight into the anti-tumor potential benefits of mango peel as a supportive
strategy for antineoplastic therapies.
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HDFa human dermal fibroblasts
H2DCFDA 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate
γH2AX phosphorylated histone 2AX
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